Clinical Trials Directory

Trials / Completed

CompletedNCT04608682

Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording

Effect of Intraoperative Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
170 (actual)
Sponsor
Beijing Tiantan Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Transcranial motor evoked potential (TcMEP) monitoring is conventionally performed during surgery without or with minimal neuromuscular blockade (NMB) because of its potential interference with signal interpretation.The feasibility of TcMEP interpretation was assessed during partial NMB in adult neurosurgical patients. However, partial NMB may interfere record of TcMEP monitoring. Sugammadex is the first highly selective antagonist that can reverse NMB. This study aims to evaluate the success rate of intraoperative muscle relax reversal by sugammadex on intraoperative TceMEP recording.

Conditions

Interventions

TypeNameDescription
DRUGSugammadexThe muscle relaxant infusion will be discontinued and a bolus of sugammadex (2mg/kg) will be given while performing TceMEPs.
DRUGSalineThe muscle relaxant infusion will be discontinued and 2ml saline will be infused, TceMEPs monitoring will be performed 5 minutes later.

Timeline

Start date
2021-08-16
Primary completion
2022-08-30
Completion
2022-08-30
First posted
2020-10-29
Last updated
2022-09-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04608682. Inclusion in this directory is not an endorsement.